A N1-Headache alternative built for CGRP renewals
N1-Headache is a respected migraine tracker, best known for its individual trigger and protector analysis: log consistently for a few months and it surfaces the factors statistically associated with your attacks. If understanding your personal triggers is your main goal, it is a thoughtful, science-minded choice.
But if you are on a CGRP preventive, your highest-stakes job is different: documenting that the treatment is working so your insurer keeps covering it. That is the specific gap Migraine Tracker: CGRP Log fills, turning your logs into the prior-authorization renewal report your neurologist and insurer need.
Based on publicly available information; competitor features may change. = partial.
Where N1-Headache shines
Credit where it's due. These are real strengths.
- Individual statistical trigger and protector analysis
- A structured, evidence-minded approach to pattern finding
- Established track record in the headache community
Where we're built different
The renewal report is the product
Baseline vs current monthly migraine days, percent reduction, breakthrough-medication days, and adherence, assembled into the one page a prior-authorization review asks for.
Disability scoring built in
MIDAS and HIT-6 are tracked from baseline to current, in the exact language clinicians and payers use for CGRP renewals.
Fast logging and private sharing
One-thumb Migraine Mode for active attacks, plus an encrypted, revocable, passcode-protected link or a clean PDF for your care team.
The honest verdict
If your priority is deep personal trigger analysis, N1-Headache is a strong, thoughtful pick. If you are on a CGRP preventive and your priority is keeping coverage, Migraine Tracker: CGRP Log is purpose-built for the renewal: the report, the disability scores, and the overuse flags come standard.
vs N1-Headache: your questions
For CGRP patients, yes. It covers daily logging and trigger tracking, then adds what a renewal depends on: the prior-authorization report, baseline-to-current MMD and percent reduction, and MIDAS/HIT-6 scoring.